References
- Gisondi P, Piaserico S, Conti A, et al. Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice. J Eur Acad Dermatol Venereol. 2020;34(6):1196–1201.
- Jeyanathan M, Afkhami S, Smaill F, et al. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol. 2020;20(10):615–632.
- Chiricozzi A, Gisondi P, Bellinato F, et al. Immune response to vaccination in patients with psoriasis treated with systemic therapies. Vaccines (Basel). 2020;8:4.
- Oliver SE, Gargano JW, Marin M, et al. The advisory committee on immunization practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1922–1924.
- Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111.
- Walsh EE, Frenck RW Jr., Falsey AR, et al. Safety and Immunogenicity of Two RNA-based Covid-19 vaccine candidates. N Engl J Med. 2020;383(25):2439–2450.
- Damiani G, Allocco F, Young Dermatologists Italian Network, et al. COVID-19 vaccination and patients with psoriasis under biologics: real-life evidence on safety and effectiveness from Italian vaccinated healthcare workers. Clin Exp Dermatol. 2021;46:1106–1108.
- Krajewski PK, Matusiak L, Szepietowski JC. Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine. J Eur Acad Dermatol Venereol. 2021 Jun 16. doi:https://doi.org/10.1111/jdv.17449.
- Gisondi P, Geat D, Naldi L, et al. Insights into Sars-CoV-2 vaccination in patients with chronic plaque psoriasis on systemic treatments. J Eur Acad Dermatol Venereol. 2021;35(6):e361–e2.
- Curtis JR, Johnson SR, Anthony DD, et al. American college of rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 1. Arthritis Rheumatol. 2021;73(7):1093–1107.
- Gelfand JM, Armstrong AW, Bell S, et al. National psoriasis foundation COVID-19 task force guidance for management of psoriatic disease during the pandemic: version 2-advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments. J Am Acad Dermatol. 2021;84(5):1254–1268.
- Simonetti O, Rizzetto G, Molinelli E, et al. Safety and efficacy of vaccines during COVID-19 pandemic in patients treated with biological drugs in a dermatological setting. Healthcare (Basel). 2021;9:4.